ODYSSEY MONO: Effect of Alirocumab 75 Mg Subcutaneously Every 2 Weeks As Monotherapy Versus Ezetimibe Over 24 Weeks (Q39052365)
scientific article published on January 1, 2015
Language:
(P31) (Q13442814)
(P304) 27-37
(P407) (Q1860)
(P433) 1
(P478) 11
(P577) Thursday, January 1, 2015
Thursday, January 1, 2015
(P921) (Q43656)
(Q417997)
(Q4726914)
(P953) https://www.tandfonline.com/doi/pdf/10.2217/fca.14.82
(P1433) (Q15765184)
(P1476) "ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks" (language: en)
(P2093) Eli M. Roth
James M. McKenney
(P2860) (Q28301815)
(Q38076875)
(Q34212424)
(Q45958080)
(Q27024882)
(Q34490730)
(Q28202519)
(Q29616310)
(Q24658039)
(Q38078264)
(Q34262650)
(Q44974421)
(Q38206839)
(Q34534248)
(Q37134467)
(Q34324688)
(Q57635512)
other details
description scientific article published on January 1, 2015

External Links